nGL 12.5 (Movantik 12.5 mg)
Generic Name: naloxegol
Pill with imprint nGL 12.5 is Purple, Elliptical / Oval and has been identified as Movantik 12.5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Movantik is used in the treatment of opioid-induced constipation; constipation, drug induced; constipation, chronic and belongs to the drug class peripheral opioid receptor antagonists. Risk cannot be ruled out during pregnancy. Movantik 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for nGL 12.5
Movantik
- Generic Name
- naloxegol
- Imprint
- nGL 12.5
- Strength
- 12.5 mg
- Color
- Purple
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Peripheral opioid receptor antagonists
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-1969
Related Images for "nGL 12.5"
More about Movantik (naloxegol)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 233 Reviews
- Drug class: peripheral opioid receptor antagonists
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.